Park Circle Company’s Kindred Biosciences, Inc. KIN Stock Holding History

Park Circle Company’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,300	Closed	-$58K	–	127
2021 Q2	$58K	Hold	6,300	–	–	0.04%	74
2021 Q1	$31K	Hold	6,300	–	–	0.03%	80
2020 Q4	$27K	Hold	6,300	–	–	0.03%	80
2020 Q3	$27K	Hold	6,300	–	–	0.03%	68
2020 Q2	$28K	Hold	6,300	–	–	0.04%	60
2020 Q1	$25K	Buy	6,300 +2,000	+47%	+$17K	0.03%	65
2019 Q4	$36K	Hold	4,300	–	–	0.02%	76
2019 Q3	$29K	Buy	4,300 +1,000	+30%	+$7.33K	0.02%	84
2019 Q2	$27K	Buy	+3,300	New	+$28.5K	0.02%	76

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Park Circle Company's KIN Position: Q3 2021 in Review

Park Circle Company sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 6,300 shares — an estimated $58K sold.

Park Circle Company first reported a position in KIN in Q2 2019 and held it in 9 quarters. The position peaked at $58K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Park Circle Company reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Park Circle Company sold 6,300 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $58K.
Park Circle Company first reported a position in Kindred Biosciences, Inc. in Q2 2019 and held it in 9 quarters.
Park Circle Company's Kindred Biosciences, Inc. position peaked at $58K in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Park Circle Company's 13F filing for Q3 2021, filed 12 Nov 2021.